Quality Measures Quality Measures for the Care of Adult Patients with Restless Legs Syndrome
暂无分享,去创建一个
R. Chervin | L. Trotti | R. Zak | C. Harrod | Cathy A Goldstein | Brian B Koo | D. Sharon
[1] Kathryn A. Lee,et al. Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation. , 2015, Sleep medicine reviews.
[2] R. Chervin,et al. Measurement of quality to improve care in sleep medicine. , 2015, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[3] J. Kassubek,et al. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications. , 2014, Sleep medicine reviews.
[4] W. Ondo. Common comorbidities and differential diagnosis of restless legs syndrome. , 2014, The Journal of clinical psychiatry.
[5] J. Winkelmann,et al. Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension , 2013, The Lancet Neurology.
[6] Y. Dauvilliers,et al. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome. , 2013, Sleep.
[7] W. Ondo,et al. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. , 2013, Mayo Clinic proceedings.
[8] Yuichi Inoue,et al. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. , 2013, Sleep medicine.
[9] Michael H. Silber. Sleep-Related Movement Disorders , 2013, Continuum.
[10] T. Wilt,et al. Treatment for Restless Legs Syndrome , 2012 .
[11] P. Jennum,et al. European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society , 2012, European journal of neurology.
[12] A. Walters,et al. Restless legs syndrome--theoretical roles of inflammatory and immune mechanisms. , 2012, Sleep medicine reviews.
[13] M. Ohayon,et al. Epidemiology of restless legs syndrome: a synthesis of the literature. , 2012, Sleep medicine reviews.
[14] Sabin R. Bista,et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. , 2012, Sleep.
[15] A. Çurgunlu,et al. Prevalence and characteristics of restless legs syndrome (RLS) in the elderly and the relation of serum ferritin levels with disease severity: hospital-based study from Istanbul, Turkey. , 2012, Archives of gerontology and geriatrics.
[16] L. Trotti,et al. Iron for restless legs syndrome. , 2012, The Cochrane database of systematic reviews.
[17] S. Ratcliffe,et al. The Relationship With Iron and Health Outcomes in Persons With Restless Legs Syndrome , 2011, Clinical nursing research.
[18] D. Riemann,et al. Dopamine agonists for restless legs syndrome. , 2011, The Cochrane database of systematic reviews.
[19] R. Davenport. Poor effect of guideline-based treatment of restless legs syndrome in clinical practice , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[20] W. Oertel,et al. Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch , 2010, BMC neurology.
[21] J. S. Valbuza,et al. The pharmacological treatment for uremic restless legs syndrome: Evidence‐based review , 2010, Movement disorders : official journal of the Movement Disorder Society.
[22] W. Poewe,et al. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels. , 2009, Sleep medicine.
[23] F. Torti,et al. Ferritin for the clinician. , 2009, Blood reviews.
[24] V. Voon,et al. Medication-related impulse control and repetitive behaviors in Parkinson's disease , 2007, Current opinion in neurology.
[25] A. Walters,et al. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. , 2007, Sleep medicine.
[26] H. Butzkueven,et al. Dopamine agonist‐induced pathological gambling in restless legs syndrome due to multiple sclerosis , 2007, Movement disorders : official journal of the Movement Disorder Society.
[27] Terry Young,et al. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. , 2006, Sleep medicine.
[28] Jennifer L. Kirwin,et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. , 2006, Archives of internal medicine.
[29] Richard P Allen,et al. Restless legs syndrome prevalence and impact: REST general population study. , 2005, Archives of internal medicine.
[30] R. Allen,et al. Correlation between rating scales and sleep laboratory measurements in restless legs syndrome. , 2004, Sleep medicine.
[31] Richard P Allen,et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. , 2004, Sleep medicine.
[32] M. Atkinson,et al. Health and Quality of Life Outcomes , 2004 .
[33] R. Allen,et al. Iron and the restless legs syndrome. , 1998, Sleep.
[34] P. Lespérance,et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria , 1997, Movement disorders : official journal of the Movement Disorder Society.
[35] S. O’Keeffe,et al. Restless legs syndrome in the elderly. , 1993, Postgraduate medical journal.
[36] W. Poewe,et al. Assessing treatment outcome in RLS trials and clinical care: CGI-I, PGI, or VAS? , 2013, Sleep medicine.
[37] D. Rye,et al. Restless legs syndrome and periodic leg movements of sleep. , 2012, Neurologic clinics.
[38] M. Silber,et al. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. , 2010, Sleep.
[39] C. Lyketsos,et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. , 2008, The Journal of neuropsychiatry and clinical neurosciences.
[40] A. Walters,et al. Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics , 2007, Movement disorders : official journal of the Movement Disorder Society.
[41] W. Hening,et al. Clinical significance of RLS , 2007, Movement disorders : official journal of the Movement Disorder Society.
[42] W. Oertel,et al. Clinical trials in restless legs syndrome—Recommendations of the European RLS Study Group (EURLSSG) , 2007, Movement disorders : official journal of the Movement Disorder Society.
[43] D. Mannino,et al. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. , 2006, Chest.
[44] M. Silber,et al. Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. , 2003, Mayo Clinic proceedings.
[45] Richard P Allen,et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. , 2003, Sleep medicine.